NEWS
High RNA Quality FFPE Tissue Blocks for Biomarker Discovery
Amsbio has expanded its range of high-quality FFPE tissues and controls specifically designed to support biomarker discovery, histopathology, translational research and assay development.
Although the...
Medicines Discovery Catapult invests in UK biotech pioneers developing novel treatments for chronic diseases
Investment and expert support will help accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases.
Two UK biotechs developing...
Biotechnology
AI Can’t Create What It Doesn’t Know: Why Inputs Matter
AI can analyse evidence faster than ever, but primary research with customers still creates the evidence pharmaceutical companies require for strategic decision making, says...
The biggest barrier to AI in life sciences isn’t the AI
Only 12% of agentic AI initiatives reached production over the past year. The challenge isn’t the technology, but ensuring AI can operate within highly...
Drug Discovery
Are animal models limiting progress in product development?
Toxicity Testing in the 21st Century (TT21C) is helping to reshape biological testing by focusing on the mechanisms that drive toxicity and disease.
Matt Stevenson,...
Turbocharging ‘good’ viruses to destroy bacteria
Scientists at the University of Leicester have developed a new technique that will turbocharge the use of phages for medicinal purposes.
The pioneering technique uses...
